0 156

Cited 18 times in

Obesity increases malignant risk in patients with branch-duct intraductal papillary mucinous neoplasm

Authors
 Emily C. Sturm  ;  Alexandra M. Roch  ;  Kristina M. Shaffer  ;  Christian M. Schmidt II  ;  Se-Joon Lee  ;  Nicholas J. Zyromski  ;  Henry A. Pitt  ;  John M. Dewitt  ;  Mohammad A. Al-Haddad  ;  Joshua A. Waters  ;  C. Max Schmidt 
Citation
 SURGERY, Vol.154(4) : 803-808, 2013 
Journal Title
 SURGERY 
ISSN
 0039-6060 
Issue Date
2013
MeSH
Adenocarcinoma, Mucinous/etiology* ; Adenocarcinoma, Mucinous/surgery ; Aged ; Body Mass Index ; Carcinoma, Pancreatic Ductal/etiology* ; Carcinoma, Pancreatic Ductal/surgery ; Carcinoma, Papillary/etiology* ; Carcinoma, Papillary/surgery ; Female ; Humans ; Male ; Neoplasm Recurrence, Local ; Obesity/complications* ; Pancreatic Neoplasms/etiology* ; Pancreatic Neoplasms/surgery ; Prospective Studies ; Risk ; Smoking/adverse effects
Abstract
BACKGROUND: Obesity is an established risk factor for pancreatic adenocarcinoma. No study has examined specifically the influence of obesity on malignant risk in patients with intraductal papillary mucinous neoplasm (IPMN), a group at substantial risk of pancreatic adenocarcinoma. We hypothesize that obesity is associated with a greater frequency of malignancy in IPMN. METHODS: Data on patients undergoing resection for IPMN between 1992 and 2012 at a high-volume university institution were collected prospectively. Clinicopathologic and demographic parameters were reviewed. Patients were classified according to World Health Organization categories of body mass index (BMI). Malignancy was defined as high-grade dysplastic or invasive IPMN. RESULTS: We collected data on 357 patients who underwent resection for IPMN. Of these, 274 had complete data for calculation of preoperative BMI and 31% had malignant IPMN. Of 254 patients with a BMI of <35 kg/m(2), 30% had malignant IPMN versus 50% in patients with BMI of ≥35 (P = .08). In branch-duct IPMN, patients with a BMI of <35 had 12% of malignant IPMN compared with 46% in severely obese patients (P = .01). Alternatively, in main-duct IPMN, no difference was found in the malignancy rate (48% vs 56%; P = .74). CONCLUSION: These findings suggest that obesity is associated with an increased frequency of malignancy in branch-duct IPMN. Obesity is a potentially modifiable risk factor that may influence oncologic risk stratification, patient counseling, and surveillance strategy.
Full Text
https://www.sciencedirect.com/science/article/pii/S0039606013004005
DOI
10.1016/j.surg.2013.07.011
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Se Joon(이세준) ORCID logo https://orcid.org/0000-0002-2695-2670
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/158484
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse